ProPublica reporters are looking into the booming business around peripheral artery disease, a condition that afflicts 6.5 million Americans over age 40. It’s caused when fatty plaque builds up in a ...

WASHINGTON, DC – OCTOBER 29, 2024 – Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with ...

Please provide your email address to receive an email when new articles are posted on . In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel ...

Rush Oak Park Hospital is the first hospital in the surrounding area to acquire and use a newly approved technology that allows vascular surgeons to see in real-time the plaque they are removing ...

WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial of the ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...

The recent New York Times article highlighting inappropriate treatment patterns among patients with peripheral artery disease (PAD) has made a serious but much needed impact on patients and physicians ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...